Sakai H, Takeoka S, Park S I, Kose T, Nishide H, Izumi Y, Yoshizu A, Kobayashi K, Tsuchida E
Department of Polymer Chemistry, Waseda University, Tokyo, Japan.
Bioconjug Chem. 1997 Jan-Feb;8(1):23-30. doi: 10.1021/bc960069p.
Poly(ethylene glycol) (PEG5000)-conjugated phosphatidylethanolamine was introduced onto the surface of hemoglobin vesicles (HbV); phospholipid vesicles encapsulating concentrated Hb (d = 0.257 +/- 0.087 micron; P50 = 32 Torr). The obtained PEG-modified HbV (HbV-PEG) was studied for use as a red cell substitute from the viewpoint of rheology, surface properties, and hemodynamics. The viscosity of the unmodified HbV suspended in saline ([Hb] = 10 g/dL) was 2.6 cP (shear rate = 358 s-1, 37 degrees C), less than that of human blood (4 cP). However, when suspended in a 5 g/dL albumin solution (HbV/ albumin), it increased to 8 cP due to the molecular interaction between albumin and vesicles, and the viscosity increased with decreasing shear rate, e.g., 37 cP at 0.58 s-1. As for the HbV-PEG/albumin, on the other hand, the viscosity was 3.5 cP at 358 s-1 and was comparable with that of human blood. Optical microscopy showed formless flocculated aggregates of the unmodified HbV, while no aggregates were confirmed for the HbV-PEG. The steric hindrance of PEG chains seemed to be effective in preventing intervesicular access and the resulting aggregation. To estimate the flow profiles in the capillaries, the suspensions were allowed to penetrate through isopore membrane filters (pore size = 0.4-8 microns, cf. capillary diameter = 4-10 microns). The penetration rate of the HbV-PEG/albumin was higher than that of the unmodified HbV/albumin due to the suppression of aggregation, whereas both of them were significantly higher than that of human blood due to the smaller size of vesicles than RBC. Ninety percent exchange transfusion was performed with the HbV-PEG/albumin or HbV/albumin in anesthetized Wistar rats (n = 6). The blood flow in the abdominal aorta increased 1.5 times, and the total peripheral resistance decreased in the HbV-PEG/albumin-administered group in comparison with the HbV/albumin group. As for the blood gas parameters, the base excess and pH remained at higher levels in the HbV-PEG/albumin group, and the O2 tension in mixed venous blood for the HbV-PEG/albumin group tended to be maintained at a higher level than that for the HbV/albumin group. Thus, the PEG modification of HbV reduced the viscosity by the suppression of aggregation and resulted in prompt blood circulation in vivo.
将聚乙二醇(PEG5000)共轭磷脂酰乙醇胺引入血红蛋白囊泡(HbV)表面;该磷脂囊泡包裹浓缩血红蛋白(d = 0.257 +/- 0.087微米;P50 = 32托)。从流变学、表面性质和血液动力学角度研究了所得的聚乙二醇修饰的HbV(HbV-PEG)作为红细胞替代物的用途。悬浮于盐溶液中([Hb] = 10 g/dL)的未修饰HbV的粘度为2.6厘泊(剪切速率 = 358 s-1,37℃),低于人体血液的粘度(4厘泊)。然而,当悬浮于5 g/dL白蛋白溶液(HbV/白蛋白)中时,由于白蛋白与囊泡之间的分子相互作用,其粘度增加至8厘泊,且粘度随剪切速率降低而增加,例如在0.58 s-1时为37厘泊。另一方面,对于HbV-PEG/白蛋白,在358 s-1时粘度为3.5厘泊,与人体血液的粘度相当。光学显微镜显示未修饰的HbV形成无定形絮凝聚集体,而HbV-PEG未观察到聚集体。聚乙二醇链的空间位阻似乎有效地防止了囊泡间的相互作用及由此导致的聚集。为估计毛细血管中的血流情况,使悬浮液通过等孔膜过滤器(孔径 = 0.4 - 8微米,参照毛细血管直径 = 4 - 10微米)。由于聚集受到抑制,HbV-PEG/白蛋白的渗透速率高于未修饰的HbV/白蛋白,而由于囊泡尺寸小于红细胞,两者的渗透速率均显著高于人体血液。对麻醉的Wistar大鼠(n = 6)用HbV-PEG/白蛋白或HbV/白蛋白进行90%的换血。与HbV/白蛋白组相比,给予HbV-PEG/白蛋白组的腹主动脉血流增加1.5倍,总外周阻力降低。至于血气参数,HbV-PEG/白蛋白组的碱剩余和pH保持在较高水平,且HbV-PEG/白蛋白组混合静脉血中的氧分压倾向于维持在高于HbV/白蛋白组的水平。因此,HbV的聚乙二醇修饰通过抑制聚集降低了粘度,并导致体内血液循环加快。